Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

Ann-Marie Roche

Director, Corporate Markets Marketing, Elsevier

Connect with Ann-Marie Roche on LinkedIn
Website:

About the author: An experienced and passionate global marketing leader in creating useful, usable and enjoyable customer experiences. I started my career as a researcher and after joining Elsevier, I have had the opportunity to get closer to the fascinating world of Life Sciences, which I now use to identify and further explore key issues such as data as a service, AI, data extraction and personalized medicine. My goal is to engage with my audience and support knowledge sharing and discussion.

Posts by Ann-Marie Roche

How publishing can help address diversity in STEM

Posted on March 30th, 2022 in Pharma R&D

The issue of diversity in science, technology, engineering and mathematics is not a new topic, but it is one that needs to be continually addressed as these sectors endeavor to be more inclusive. And it is possible that publishing, an area that itself has work to do in diversity, could provide some metrics to help confront the diversity deficit.

(more…)

Umesh Nandal: Chemist and data scientist in one

Posted on March 10th, 2022 in AI & Data

Umesh Nandal is a Director of Data Science at Elsevier. As an AI expert with a Master’s in Chemistry, he embodies what Elsevier brings to the table – an actionable fusion of data and domain expertise. “Cross-functional teams combining data science, tech and domain knowledge is the only way we can achieve our collective goal: curing disease,” says Umesh.

(more…)

Can predictive retrosynthesis become a valuable part of a chemist’s toolkit?

Posted on January 18th, 2022 in Chemistry

“Yes. I was amazed by the Reaxys Predictive Retrosynthesis technology,” says Moritz Classen of the Carreira Research Group at ETH Zurich. He and his colleagues spent months evaluating the tool as they applied it into their daily workflows. “It’s already very user-friendly and really does save a lot of time”. So, what can chemists exactly expect when using predictive retrosynthesis tools?

(more…)

AI-driven innovation in life sciences: Unlocking the page – 20+ years of digital innovation at Elsevier

Posted on December 2nd, 2021 in AI & Data

Mark Sheehan is VP Data Science on Elsevier’s Life Science team. His 22 years at the company maps closely with Elsevier’s digital journey over that time. And today, pharmaceutical companies can follow a similar journey – albeit highly accelerated – using Elsevier’s latest AI-driven R&D boosters. Mark has enjoyed many valuable experiences along the way, from the joys of cracking open a newly printed book, to enabling people to speedily crack new synthetic pathways at scale. “Yes, innovation always involves new technology. But it’s equally about human collaboration,” he says.

(more…)

  1. 1
  2. 2
  3. 3
  4. 4
  5. 9